Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Implementation
Transplantation
.
2018 Mar;102(3):e122-e123.
doi: 10.1097/TP.0000000000002040.
Authors
Mohamed Azab
1
,
Syed Shah
1
,
Xibei Liu
2
,
Amaan Shafi
1
,
Tamarah Al Dawoodi
1
,
Yousif Elmofti
1
,
Mary Froehlich
3
,
Johnson Ukken
3
,
Ji Won Yoo
1
Affiliations
1
Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
2
Department of Medicine, College of Medicine, University of Arizona, Tuscon, AZ.
3
University of Nevada Reno School of Medicine, Reno, NV.
PMID:
29319614
DOI:
10.1097/TP.0000000000002040
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Immunotherapy, Adoptive
Interrupted Time Series Analysis*
Pain Management
Substances
Antiviral Agents